CTI BioPharma Corp.

(CTIC) Trade

By |

Profile

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Contact Information

Website: www.ctibiopharma.com
Email: jbalanova@troutgroup.com
Main Phone: +1 206 282-7100
Address: 3101 Western Avenue
Address 2: Suite 800
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98121

Issuer Information

Exchange: NSC
CEO: Adam R. Craig
Employees: 58
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Contact Information

Website: www.ctibiopharma.com
Email: jbalanova@troutgroup.com
Main Phone: +1 206 282-7100
Address: 3101 Western Avenue
Address 2: Suite 800
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98121

Issuer Information

Exchange: NSC
CEO: Adam R. Craig
Employees: 58
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.83 $ 0.0205 (2.55%)
Last Price 0.83 Change $ 0.0205 Change % 2.55 Tick N/A
Bid 0.50 Bid Size 900.00 Ask 0.85 Ask Size 1,000.00
Open 0.82 High 0.84 Low 0.81 Prev Close 0.81
Last Trade Volume 65,421 52 Wk Hi 4.08 52 Wk Low 0.60
Market Cap 47.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,978,725.00 EPS (TTM) -0.62 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 24
Number of Buys 0 5
Number of Sells 0 19
Net Activity 0 -1661146
Last 10 Buys Shares
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Last 10 Sell Shares
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
Richard L. Love 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7.5 7.5 7.5 7.5
Low Target Price Estimate 7.5 7.5 7.5 7.5
Mean Target Price Estimate 7.5 7.5 7.5 7.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/15/16 08/15/16 08/15/16 08/15/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3